Ontogeny of pituitary and serum growth hormone in growing turkeys as measured by radioimmunoassay and radioreceptor assay.
Some mammalian studies have revealed a wide discrepancy in pituitary and circulating growth hormone (GH) measurements determined by immunological and biological assay methods. Recent studies demonstrating that avian GH exists in numerous isoforms raise concerns that immunological measurement of GH may not accurately reflect the amount of biologically active hormone present. We sampled eight different male turkeys of a commercial strain weekly until 6 wk of age, and then biweekly until 20 wk. Total pituitary GH content and serum GH concentration were measured by avian GH RIA and radioreceptor assay (RRA). The highest mean serum GH concentration occurred at 3 wk, and the ontogeny of serum GH content from 1 to 8 wk was similar whether measured by RIA or RRA. Pituitary GH content was highest at 6 wk, but RIA and RRA estimates differed markedly throughout the study. Pituitary content of biologically active GH, as estimated by RRA, exceeded that of immunologically active GH from 2 to 10 wk, whereas the reverse was true at 14, 18, and 20 wk. We conclude that this avian GH RIA accurately measures bioactive circulating turkey GH, but that the pituitary of the young turkey may contain bioactive GH isoforms that have poor immunological activity in our RIA.
D000367:Age Factors; D000818:Animals; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D008297:Male; D010902:Pituitary Gland / Q000254:growth & development / Q000378:metabolism*; D011863:Radioimmunoassay / Q000662:veterinary; D011869:Radioligand Assay / Q000662:veterinary; D014422:Turkeys / Q000097:blood / Q000254:growth & development* / Q000378:metabolism
D013006:Growth Hormone